In 2019, GARDP launched “5 BY 25”, an initiative to develop five new antibiotic treatments during the period 2020-2025. Part of a broader strategy, 5 BY 25 signaled GARDP’s ambition to develop its R&D and access portfolio and expand its role in global efforts to counter antibiotic resistance. This webinar took stock of what GARDP accomplished and learned over the past five years, and how it is leveraging progress to advance sustainable antibiotic R&D and access focused on public health needs.
Speakers
- Anand Anandkumar – Bugworks
- Manica Balasegaram – GARDP
- Glenda Gray – SAMRC & Wits University
- David Paterson – ADVANCE-ID
Moderated by Herman Goossens, University of Antwerp.
You can read here the GARDP’s 5 BY 25 Report: Laying the foundation for sustainable antibiotic R&D and access.
This live webinar including interactive Q&A session was broadcast on 15 January 2026.
If you have questions or comments, please let us know: revive@gardp.org.